LXRX
Price
$2.00
Change
-$0.02 (-0.99%)
Updated
Sep 11 closing price
Capitalization
887.69M
60 days until earnings call
Intraday BUY SELL Signals
PLRX
Price
$1.17
Change
+$0.04 (+3.54%)
Updated
Sep 11 closing price
Capitalization
73.07M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LXRX vs PLRX

LXRX vs PLRX Comparison Chart in %
View a ticker or compare two or three
VS
LXRX vs. PLRX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXRX is a StrongBuy and PLRX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXRX($888M) has a higher market cap than PLRX($73.1M). LXRX YTD gains are higher at: 73.913 vs. PLRX (-4.098). LXRX has higher annual earnings (EBITDA): -52.25M vs. PLRX (-90.02M). LXRX has more cash in the bank: 191M vs. PLRX (158M). PLRX has less debt than LXRX: PLRX (28.7M) vs LXRX (59.3M). LXRX has higher revenues than PLRX: LXRX (41.5M) vs PLRX (0).
LXRXPLRXLXRX / PLRX
Capitalization888M73.1M1,215%
EBITDA-52.25M-90.02M58%
Gain YTD73.913-4.098-1,803%
P/E RatioN/AN/A-
Revenue41.5M0-
Total Cash191M158M121%
Total Debt59.3M28.7M207%
FUNDAMENTALS RATINGS
LXRX vs PLRX: Fundamental Ratings
LXRX
PLRX
OUTLOOK RATING
1..100
7490
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4558
P/E GROWTH RATING
1..100
18100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LXRX's Valuation (73) in the Biotechnology industry is in the same range as PLRX (84) in the null industry. This means that LXRX’s stock grew similarly to PLRX’s over the last 12 months.

LXRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PLRX (100) in the null industry. This means that LXRX’s stock grew similarly to PLRX’s over the last 12 months.

LXRX's SMR Rating (97) in the Biotechnology industry is in the same range as PLRX (98) in the null industry. This means that LXRX’s stock grew similarly to PLRX’s over the last 12 months.

LXRX's Price Growth Rating (45) in the Biotechnology industry is in the same range as PLRX (58) in the null industry. This means that LXRX’s stock grew similarly to PLRX’s over the last 12 months.

LXRX's P/E Growth Rating (18) in the Biotechnology industry is significantly better than the same rating for PLRX (100) in the null industry. This means that LXRX’s stock grew significantly faster than PLRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LXRXPLRX
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (LXRX: $2.00 vs. PLRX: $1.17)
Brand notoriety: LXRX and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXRX: 130% vs. PLRX: 33%
Market capitalization -- LXRX: $887.69M vs. PLRX: $73.07M
LXRX [@Biotechnology] is valued at $887.69M. PLRX’s [@Biotechnology] market capitalization is $73.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXRX’s FA Score shows that 1 FA rating(s) are green while PLRX’s FA Score has 0 green FA rating(s).

  • LXRX’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, LXRX is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 6 bullish TA indicator(s).

  • LXRX’s TA Score: 4 bullish, 5 bearish.
  • PLRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than LXRX.

Price Growth

LXRX (@Biotechnology) experienced а -10.71% price change this week, while PLRX (@Biotechnology) price change was +0.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

LXRX is expected to report earnings on Nov 11, 2026.

PLRX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
LXRX
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTLLX34.180.57
+1.70%
Glenmede Disciplined US Growth Eq Ptf
AMCFX45.890.28
+0.61%
American Funds AMCAP F-2
RYMPX275.74N/A
N/A
Rydex Precious Metals H
FRINX12.20N/A
N/A
Fidelity Advisor Real Estate Income A
TRMNX24.56N/A
N/A
T. Rowe Price Mid-Cap Index

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with PLRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
-0.99%
PLRX - LXRX
58%
Loosely correlated
+3.54%
VKTX - LXRX
38%
Loosely correlated
-0.47%
VCYT - LXRX
37%
Loosely correlated
-2.76%
ABOS - LXRX
35%
Loosely correlated
+2.10%
NTLA - LXRX
35%
Loosely correlated
-1.59%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+3.54%
LXRX - PLRX
58%
Loosely correlated
-0.99%
SION - PLRX
43%
Loosely correlated
+3.02%
ABEO - PLRX
37%
Loosely correlated
-1.19%
AXSM - PLRX
35%
Loosely correlated
+4.56%
RCKT - PLRX
35%
Loosely correlated
-3.74%
More